Shelly C Lu

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Topics

Top Venues

Nature communications

The Journal of biological chemistry

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Urko M Marigorta, Óscar Millet, Shelly C Lu, Jose M Mato
Dysfunctional VLDL metabolism in MASLD. NPJ metabolic health and disease 2 (1) (2024)
Bing Yang, Jing Zhang, Jiaohong Wang, Wei Fan, Lucía Barbier-Torres, Xi Yang, Monica Anne R Justo, Ting Liu, Yongheng Chen, Justin A Steggerda, Komal Ramani, Shelly C Lu, Heping Yang
CSNK2A1-mediated MAX phosphorylation upregulates HMGB1 and IL-6 expression in cholangiocarcinoma progression. Hepatology communications 7 (7) (2023)
Lucía Barbier-Torres, Ben Murray, Jin Won Yang, Jiaohong Wang, Michitaka Matsuda, Aaron Robinson, Aleksandra Binek, Wei Fan, David Fernández-Ramos, Fernando Lopitz-Otsoa, Maria Luque-Urbano, Oscar Millet, Nirmala Mavila, Hui Peng, Komal Ramani, Roberta A Gottlieb, Zhaoli Sun, Suthat Liangpunsakul, Jeffrey H Albrecht, Jennifer E Van Eyk, Jose M Mato, Shelly C Lu
Depletion of mitochondrial methionine adenosyltransferase α1 triggers mitochondrial dysfunction in alcohol-associated liver disease. Nature communications 13 (1) (2022)
Ibon Martínez-Arranz, Chiara Bruzzone, Mazen Noureddin, Ruben Gil-Redondo, Itziar Mincholé, Maider Bizkarguenaga, Enara Arretxe, Marta Iruarrizaga-Lejarreta, David Fernández-Ramos, Fernando Lopitz-Otsoa, Rebeca Mayo, Nieves Embade, Elizabeth Newberry, Bettina Mittendorf, Laura Izquierdo-Sánchez, Vaclav Smid, Jorge Arnold, Paula Iruzubieta, Ylenia Pérez Castaño, Marcin Krawczyk, Urko M Marigorta, Martine C Morrison, Robert Kleemann, Antonio Martín-Duce, Liat Hayardeny, Libor Vítek, Radan Brůha, Rocío Aller de la Fuente, Javier Crespo, Manuel Romero, Jesus M Banales, Marco Arrese, Kenneth Cusi, Elisabetta Bugianesi, Samuel Klein, Shelly C Lu, Quentin Mark Anstee, Óscar Millet, Nicholas O Davidson, Cristina Alonso, Jose M Mato
Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles. Hepatology (Baltimore, Md.) 76 (4) (2022)
David Matye, Sumedha Gunewardena, Jianglei Chen, Huaiwen Wang, Yifeng Wang, Mohammad Nazmul Hasan, Lijie Gu, Yung Dai Clayton, Yanhong Du, Cheng Chen, Jacob E Friedman, Shelly C Lu, Wen-Xing Ding, Tiangang Li
TFEB regulates sulfur amino acid and coenzyme A metabolism to support hepatic metabolic adaptation and redox homeostasis. Nature communications 13 (1) (2022)
Pablo Fernandez-Tussy, Rubén Rodríguez-Agudo, David Fernández-Ramos, Lucía Barbier-Torres, Imanol Zubiete-Franco, Sergio López de Davalillo, Elisa Herraez, Naroa Goikoetxea-Usandizaga, Sofia Lachiondo-Ortega, Jorge Simón, Fernando Lopitz-Otsoa, Virginia Gutiérrez-de Juan, Misti V McCain, Maria J Perugorria, Jon Mabe, Nicolás Navasa, Cecília Maria Pereira Rodrigues, Isabel Fabregat, Loreto Boix, Victor Sapena, Juan Anguita, Shelly C Lu, Jose M Mato, Jesus M Banales, Erica Villa, Helen L Reeves, Jordi Bruix, Maria Reig, Jose J G Marin, Teresa C Delgado, María Luz Martínez-Chantar
Anti-miR-518d-5p overcomes liver tumor cell death resistance through mitochondrial activity. Cell death & disease 12 (6) (2021)
Liqing Lu, Jing Zhang, Wei Fan, Yuan Li, Jiaohong Wang, Tony W H Li, Lucia Barbier-Torres, Jose M Mato, Ting Liu, Jeffrey H Albrecht, Michitaka Matsuda, Maria Lauda Tomasi, Neil A Bhowmick, Heping Yang, Shelly C Lu
Deregulated 14-3-3ζ and methionine adenosyltransferase α1 interplay promotes liver cancer tumorigenesis in mice and humans. Oncogene 40 (39) (2021)
Qinglan Wang, So Yeon Kim, Hiroshi Matsushita, Zhijun Wang, Vijay Pandyarajan, Michitaka Matsuda, Koichiro Ohashi, Takashi Tsuchiya, Yoon Seok Roh, Calvin Kiani, Yutong Zhao, Michael Chan, Suzanne Devkota, Shelly C Lu, Tomoko Hayashi, Dennis A Carson, Jeffrey H Albrecht
Oral administration of PEGylated TLR7 ligand ameliorates alcohol-associated liver disease via the induction of IL-22. Proceedings of the National Academy of Sciences of the United States of America 118 (1) (2020)
Alexandra Gangi, Shelly C Lu
Chemotherapy-associated liver injury in colorectal cancer. Therapeutic advances in gastroenterology 13 (2020)
Lucía Barbier-Torres, Shelly C Lu
Prohibitin 1 in liver injury and cancer. Experimental biology and medicine (Maywood, N.J.) 245 (5) (2020)
Walid S Ayoub, Justin Steggerda, Ju Dong Yang, Alexander Kuo, Vinay Sundaram, Shelly C Lu
Current status of hepatocellular carcinoma detection: screening strategies and novel biomarkers. Therapeutic advances in medical oncology 11 (2019)
Jin Won Yang, Ben Murray, Lucia Barbier-Torres, Ting Liu, Zhenqiu Liu, Heping Yang, Wei Fan, Jiaohong Wang, Yuan Li, Ekihiro Seki, José M Mato, Shelly C Lu
The mitochondrial chaperone Prohibitin 1 negatively regulates interleukin-8 in human liver cancers. The Journal of biological chemistry 294 (6) (2018)